Evidence map›Paper›PMID 21458583›Full record

ReviewMicrobes and infection2011

Chlamydia persistence -- a tool to dissect chlamydia--host interactions.

R V Schoborg

Abstract readReview
In one paragraph

Review in Microbes and infection, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Kaempferol inhibitsFrontiers in microbiology · 2026
    Article
  4. Review
  5. Journal of bacteriology · 2025
    Review
  6. Virulence · 2024
    Review
  7. Chlamydiosis in Animals.Animals : an open access journal from MDPI · 2024
    Review
  8. Review
  9. Review
  10. Molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2023
    Review
  11. Beta lactamase-producingCurrent research in microbial sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bioactive Compounds ofMicroorganisms · 2019
    Article
  17. Article
  18. Article
  19. Journal of pathogens · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

R V SchoborgDepartment of Microbiology, East Tennessee State University, James H. Quillen College of Medicine, Johnson City, TN 37614-1708, USA. schoborg@etsu.edu.

Funding

Development of an in vivo model of chlamydial persistence.R21AI082322 · NIAID · EAST TENNESSEE STATE UNIVERSITY · PI SCHOBORG, ROBERT V. · 2009 to 2010
$387k
Can Chlamydial Infection Increase Host Mutation Frequency?R15AI078373 · NIAID · EAST TENNESSEE STATE UNIVERSITY · PI SCHOBORG, ROBERT V. · 2009 to 2009
$211k
NIAID NIH HHS AI078373-01A1NIAID NIH HHS AI082322-01NIAID NIH HHS R15 AI078373NIAID NIH HHS R21 AI082322
6 · The paper itself

Abstract

Under stress, chlamydiae can enter a non-infectious but viable state termed persistence. In the absence of a tractable genetic system, persistence induction provides an important experimental tool with which to study these fascinating organisms. This review will discuss examples of: i) persistence studies that have illuminated critical chlamydiae/host interactions; and ii) novel persistence models that will do so in the future.

Indexed as

Host-Pathogen InteractionsAnimalsCell LineChlamydiaChlamydia InfectionsHumansInterferon-gammaModels, BiologicalNicotianaPhenotypePurinergic AgonistsSmokeTropismInterferon-gammaPurinergic AgonistsSmoke

Identifiers

PMID21458583
PMCPMC3636554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.